| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing oxaliplatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxaliplatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely oxaliplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxaliplatin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely oxaliplatin 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxaliplatin (substance) |
Inferred relationship |
Some |
|
| oxaliplatin 5 mg/ml injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxaliplatin (substance) |
Inferred relationship |
Some |
|
| oxaliplatin 5 mg/ml pulver til injektionsvæske, opløsning, hætteglas a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxaliplatin (substance) |
Inferred relationship |
Some |
|
| Oxaliplatin desensitization therapy (regime/therapy) |
Using substance (attribute) |
False |
Oxaliplatin (substance) |
Inferred relationship |
Some |
1 |
| Oxaliplatin desensitization therapy (regime/therapy) |
Using substance (attribute) |
True |
Oxaliplatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing oxaliplatin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxaliplatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely oxaliplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxaliplatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely oxaliplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxaliplatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely oxaliplatin 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxaliplatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely oxaliplatin 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxaliplatin (substance) |
Inferred relationship |
Some |
1 |
| Oxaliplatin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxaliplatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only oxaliplatin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxaliplatin (substance) |
Inferred relationship |
Some |
1 |
| FOLFIRINOX antineoplastic chemotherapy regimen |
Direct substance |
True |
Oxaliplatin (substance) |
Inferred relationship |
Some |
3 |
| Product containing precisely oxaliplatin 5 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxaliplatin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely oxaliplatin 5 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxaliplatin (substance) |
Inferred relationship |
Some |
1 |
FHIR